Jeanne D Seibert MD 601 E Hampden Ave STE 160, Englewood, CO 80113 (303)7884662 (phone), (303)7887437 (fax)
Education:
Medical School University of Miami, Miller School of Medicine Graduated: 1997
Procedures:
Arthrocentesis Cardiac Stress Test Destruction of Benign/Premalignant Skin Lesions Electrocardiogram (EKG or ECG) Pulmonary Function Tests Vaccine Administration
Dr. Bishop graduated from the University of Miami, Miller School of Medicine in 1997. He works in Englewood, CO and specializes in Internal Medicine. Dr. Bishop is affiliated with Swedish Medical Center.
McCarran Medical Clinic & Pharmacy 5757 Wayne Newton Blvd, Las Vegas, NV 89111 (702)2616707 (phone), (702)2616744 (fax)
Languages:
English Spanish
Description:
Mr. Bishop works in Las Vegas, NV and specializes in Internal Medicine. Mr. Bishop is affiliated with Desert Springs Hospital Medical Center and Sunrise Hospital & Medical Center.
Paul L. Hermonat - Little Rock AR J. Gerald Quirk - Little Rock AR Brian Bishop - Harrison AR Han Li - Little Rock AR
Assignee:
The Board of Trustees of the University of Arkansas - Little Rock AR
International Classification:
C12N 1586
US Classification:
435456
Abstract:
The present invention provides a method of human gene therapy using AAV vectors with essentially wildtype phenotype. Genes of 900 bases or less can be inserted into wildtype AAV and still allow the resulting vector to have a largely wildtype phenotype. For example, several antisense genes could be inserted and still allow packaging. Such wildtype vectors have several advantages. First, high titers of such vectors is easy to accomplish. Second, the vectors, since they include the Rep78 gene, integrate specifically into human chromosome 19. Third, such vectors, being wildtype, spread after their initial introduction. Another method for use of large wildtype AAV genomes is as complementors for fully defective AAV vectors. Such complementors can be delivered by virus infection and, be introduced easily into 100% of the cells used to produce virus. Viral infection is superior to synthetic techniques for introducing DNA into tissue culture producer cells.